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Abstract
& Previously, we demonstrated that enhancing cholinergic ac-
tivity during a working memory (WM) task improves perform-
ance and reduces blood flow in the right anterior middle/
superior frontal cortex, an area known to be important for WM.
The purpose of this study was to evaluate the interaction
between WM task demands and cholinergic enhancement on
neural responses in the prefrontal cortex. Regional cerebral
blood flow (rCBF) was measured using H2
15O and positron
emission tomography, as 10 young healthy volunteers per-
formed a parametrically varied match-to-sample WM for faces
task. For each item, a picture of a face was presented, followed
by a delay (1, 6, 11, or 16 sec), then by the presentation of two
faces. Subjects were instructed to identify which face they pre-
viously had seen. For control items, nonsense pictures were
presented in the same spatial and temporal manner. All con-
ditions were performed during an intravenous infusion of
saline and physostigmine (1 mg/hr). Subjects were blind to
the substance being infused. Reaction time increased signifi-
cantly with WM delay, and physostigmine decreased reaction
time across delay conditions. Significant task-related rCBF in-
creases during saline infusion were seen in superior frontal,
middle frontal, and inferior frontal regions, and the response
magnitudes in the regions increased systematically with task
difficulty. In all of these prefrontal regions, physostigmine ad-
ministration significantly reduced rCBF during task, particu-
larly at longer task delays, so that no correlation between task
delay and rCBF was observed. In the ventral visual cortex,
physostigmine increased rCBF at longer task delays in medial
regions, and decreased rCBF over delay conditions in lateral
cortical areas. These results indicate that, during cholinergic
potentiation, brain activity in prefrontal regions is not modu-
lated by increases in WM task demands, and lends further
support to the hypothesis that cholinergic modulation en-
hances visual processing, making the task easier to perform,
and thus, compensate for the need to recruit prefrontal cor-
tical regions as task demands increase. &
INTRODUCTION
Working memory (WM) denotes a cognitive process that
temporarily maintains an active representation of in-
formation for further processing or recall (Baddeley,
2003; Baddeley, Logie, Bressi, Della Sala, & Spinnler,
1986). The role of the cholinergic system in WM as well
as in other cognitive functions is well established, in that
enhancing cholinergic activity improves performance
on WM and attention tasks (Furey, Pietrini, Alexander,
Mentis, et al., 2000; Furey, Pietrini, Alexander, Schapiro,
& Horwitz, 2000; Furey, Pietrini, & Haxby, 2000; Furey
et al., 1997; Robbins, 1997; Glasky, Melchior, Pirzadeh,
Heydari, & Ritzmann, 1994; Terry, Jackson, & Buccafusco,
1993), whereas blocking normal cholinergic function
impairs performance (Robbins, 1997; Dawson & Iversen,
1993; Rusted & Warburton, 1988). In the last several years,
functional brain imaging studies have begun to reveal
neural mechanisms associated with cholinergic effects on
cognitive function in humans (Sarter, Nelson, & Bruno,
2005; Bentley, Vuilleumier, Thiel, Driver, & Dolan, 2003a;
Furey, Pietrini, Alexander, Schapiro, et al., 2000; Furey,
Pietrini, & Haxby, 2000; Sarter & Bruno, 2000; Furey et al.,
1997; Mesulam, 1995).
In a series of studies with positron emission tomogra-
phy (PET) and functional magnetic resonance imaging
(fMRI), we investigated how enhancement of cholinergic
activity by the anticholinesterase agent physostigmine
modulates neural response to a WM task across brain
regions (Freo et al., 2005; Furey, Pietrini, Alexander,
Schapiro, et al., 2000; Furey, Pietrini, & Haxby, 2000;
Furey et al., 1997), and showed a selective reduction in
task-specific neural activity in prefrontal cortical areas
known to be critical for WM function. We also demon-
strated that cholinergic enhancement improved task
performance, and that the magnitude of improvement
correlated with the magnitude of change in neural activity
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in multiple WM brain regions. Specifically, improvement in
task performance correlated with increased neural activity
in medial visual areas associated with early perceptual
processing and with decreased activity in prefrontal WM
regions (Furey, Pietrini, Alexander, Schapiro, et al., 2000).
An fMRI study that evaluated the influence of choliner-
gic modulation on each WM component (i.e., encoding,
maintenance, recognition) also showed that prefrontal
activity was diminished across the WM task components,
and further demonstrated that increased cholinergic
function was associated with selective increases in neu-
ral response to task-relevant stimuli in ventral temporal
and occipital visual cortical regions, particularly during
stimulus encoding (Furey, Pietrini, & Haxby, 2000). In
addition to the increase in selectivity of visual process-
ing, these earlier studies also demonstrated reduced ac-
tivity in lateral visual cortical regions during WM and
cholinergic enhancement (Freo et al., 2005; Furey,
Pietrini, & Haxby, 2000; Furey et al., 1997) while the me-
dial visual cortex showed relative increases in blood flow
that correlated with decreases in reaction time (Furey,
Pietrini, Alexander, Schapiro, et al., 2000), results that
may suggest a sharpened representation of the visual
stimulus through signal-to-noise processes that both in-
crease response to signal and decrease response to noise.
Together, these findings have led us to the hypothesis
that cholinergic augmentation improves the efficiency of
perceptual processing of task-relevant information, and
thus, provides an enhanced visual percept during stimu-
lus encoding. This, in turn, may reduce the effort re-
quired to perform the WM task and the need to recruit
prefrontal cortical areas (Furey, Pietrini, & Haxby, 2000).
This hypothesis is supported also by reports which in-
dicate that increasing WM task difficulty, such as by mod-
ulating visuoperceptual integrity (Grady et al., 1996),
length of the WM retention interval (Grady et al., 1998;
Barch et al., 1997; Haxby, Ungerleider, Horwitz, Rapoport,
& Grady, 1995), or memory load (Braver et al., 1997), is
associated with systematic increases in the magnitude
of neural response in WM regions of the prefrontal cor-
tex. A parametric task could be utilized to evaluate the
influence of cholinergic modulation on neural activity
in prefrontal cortical regions that respond specifically to
changes in WM task demands.
In the present study, we measured neural responses
while subjects performed a visual WM task whose main-
tenance delay duration was varied parametrically before
and during pharmacological modulation of cholinergic
activity using physostigmine. We modulated WM delay
to more directly assess the interaction between cholin-
ergic enhancement and neural responses to WM task de-
mands (Barch et al., 1997). Previously, we hypothesized
that cholinergic modulation reduced task difficulty by
enhancing the perceptual processing of relevant visual
information. In this experiment, we expected that pre-
frontal brain regions that respond to task difficulty by
selectively increasing response as task demands increase
also would show selective responses to cholinergic en-
hancement, whereas other prefrontal areas that do re-
spond during task performance, but are not modulated
differentially by increasing task demands, would not be
modulated by cholinergic enhancement. In addition, vi-
sual processing areas in occipital and/or temporal ex-
trastriate regions would show a reduction in the overall
extent of activity and an increase in neural activity in
those regions responding during the visual WM task,
under cholinergic modulation.
METHODS
Ten (5 men, 5 women; mean age ± SD = 26 ± 1 years)
right-handed healthy volunteers were studied. All par-
ticipants underwent clinical, neurological, and psychiat-
ric examinations and laboratory tests (including routine
blood and urine tests; liver, renal, and endocrinological
panels; EEG; EKG; chest X-rays; structural brain MRI) to
rule out the history or presence of any relevant medical,
neurological, or psychiatric disorders and use of sub-
stance that could affect brain function or metabolism. All
subjects were nonsmokers and had been medication-
free for at least 4 weeks prior to the study, including
over-the-counter medications. Written informed consent
was obtained from all participants prior to their enrol-
ment into the study and after explanation of the study
procedure and risks involved (according to protocol
93-AG-193 approved by the National Institute on Aging
Intramural Review Board).
Prior to PET scanning, catheters were placed in a ra-
dial artery for drawing blood samples and in antecubital
veins of both arms for injection of the isotope and for
infusion of drug and/or saline solution. Absolute re-
gional cerebral blood flow (rCBF) was measured using
H2
15O and PET (Scanditronix PC2048-15B PET Scanner,
Uppsala, Sweden; full width at half maximum = 6.5 mm)
over ten 4-min scans during a parametrically varied
visual WM task or a sensorimotor control task. For each
WM item, a picture of a face was presented for 3 sec,
followed by a delay of 1, 6, 11, or 16 sec, and finally, two
faces were shown side-by-side for 3 sec (Figure 1). Pic-
tures were black-and-white images of male and female
faces. Target and distracter stimuli were always of the
same sex. Subjects were instructed to indicate which of
the two faces shown during recognition matched the
face presented during encoding by pressing hand-held
response buttons. For the sensorimotor control task,
nonsense pictures were presented in the same spatial
and temporal manner, but there was no memory com-
ponent in the task. Subjects were instructed to press
both response buttons following the presentation of side-
by-side nonsense pictures (Figure 1). The five task con-
ditions were presented in randomized order to each
subject, first during an intravenous infusion of saline
solution and, subsequently, during intravenous infusion
of physostigmine (1.93 mg/hr for 10 min, followed by
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0.82 mg/hr to completion of the study; Furey et al., 1997),
for a total of 10 scans. Prior to the infusion of physo-
stigmine, 0.2 mg of the peripheral cholinergic antagonist,
glycopyrrolate, was administered intravenously to reduce
potential cholinergic side effects (Oduro, 1975). A 30-min
delay occurred following the physostigmine infusion,
prior to cognitive testing. Heart rate, respiratory rate,
blood pressure, and blood oxygen saturation levels were
monitored continuously throughout each study. All sub-
jects were unaware of when they would receive physo-
stigmine infusion during the PET scan examination.
PET using H2
15O produces a temporal window during
which data are acquired for each scan. In this study, data
were acquired for the same period of time during each
task delay condition, and as a result, the number of trials
per delay condition varied so that more trials were ob-
tained in the short task delay conditions and fewer trials
were obtained in the long delay conditions. As a result,
as the task delay increased, the percentage of the PET
acquisition period attributed to visual processing (i.e.,
face stimuli) decreased and the percentage of the ac-
quisition period attributed to information maintenance
(i.e., delay period) increased.
Reaction time and accuracy data were obtained for five
of the subjects (the remaining performance data were
not retrievable due to hardware dysfunction) and were
analyzed using repeated measures analysis of variance
(repeated Reaction time by Delay length by Infusion con-
dition). Drug effects were assessed using one-tailed tests
based on previously reported findings (Furey, Pietrini, &
Haxby, 2000; Furey et al., 1997).
Using SPM99 (Wellcome Department of Cognitive
Neurology, Institute of Neurology, University College,
London; Friston et al., 1995: www.fil.ion.ucl.ac.uk/spm/),
PET images were registered to correct for between-scan
movements, spatially normalized to the Talairach and
Tournoux (1988) brain atlas, and smoothed using a 12 
12  12 mm Gaussian filter.
Brain regions showing statistically significant rCBF
increases in response to the WM task during saline so-
lution and during physostigmine infusion were deter-
mined separately by contrasting all task scans combined
(1, 6, 11, and 16 sec delays) to the sensorimotor control
condition (individual voxel level of p < .05, with a mini-
mum of 50 contiguous significant voxels). These results
were used to create masks that restricted the search
volume in subsequent analyses, and therefore, we uti-
lized a less conservative statistical criteria so that search
volumes for drug effects were inclusive. The correc-
tion for multiple comparisons in analyses implement-
ing the masks was determined based on the restricted
search volumes.
Brain regions showing significant Task  Drug inter-
actions were identified by contrasting rCBF during WM
conditions combined over task delays (relative to the
sensorimotor control task) between the drug and pla-
cebo conditions. To identify rCBF decreases during task
associated with physostigmine infusion, the interaction
contrast was masked by the activation map from the pla-
cebo condition. To identify rCBF increases during task
associated with physostigmine, the interaction contrast
was masked by the activation map from the physostig-
mine condition. For all interactions, statistical signifi-
cance was assumed at a voxel level of p < .005 and a
corrected cluster level of p  .05.
To identify brain areas showing a positive or negative
linear relation between rCBF response and task delay,
voxel by voxel linear trends analyses were performed with-
Figure 1. Experimental
paradigm. Ten 4-min PET
scans were obtained using a
parametrically varied visual
WM task (face recognition) and
a sensorimotor control task.
During the match-to-sample
WM task, a stimulus array
composed of three equal-sized
squares, one centered above
two positioned side-by-side,
was presented. Each trial
began with the presentation of
a picture of a face in the top
square, followed by a delay
interval that varied between 1,
6, 11, or 16 sec, followed by
two faces shown in the bottom
two squares. Participants were
asked to indicate which of the
two faces matched the face
shown in the top square. The
control task included the presentation of nonsense stimuli, and participants were asked to press both buttons. The five task conditions (control
and 4 WM delays) were presented in randomized order for each subject, first during an intravenous placebo infusion of saline and,
subsequently, during intravenous infusion of physostigmine.
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in the masked regions that responded to task under saline
or physostigmine infusion; significance was assumed at a
voxel level of p < .005 and required 25 contiguous sig-
nificant voxels.
Twenty-millimeter spheres were placed on local maxima
from significant interaction effects and linear trends anal-
yses, and volume mean rCBF values were obtained. These
volume means were used to display experimental effects.
RESULTS
Reaction time increased with increasing task delay (n = 5;
F = 19.23, p < .001). Physostigmine significantly decreased
reaction time relative to saline placebo (F = 5.4, p < .05),
and this effect did not differ across task delays (Figure 2).
Performance accuracy exceeded 95% correct on all delay
conditions, under both placebo and physostigmine con-
ditions. No change in performance accuracy was observed
following physostigmine administration ( p > .20).
Brain regions showing increases in rCBF during the
WM task under placebo and drug conditions, and re-
gions showing significant interactions in rCBF between
task and drug conditions, are summarized in Table 1 and
have been superimposed onto the right hemisphere of
a brain template in Figure 3.
Under placebo conditions, increases in task-related rCBF
were observed bilaterally throughout the prefrontal cortex
with loci in inferior frontal and anterior middle frontal
cortical areas, as well as in the insular cortex, and in oc-
cipital and temporal visual extrastriate regions. Increases
were observed unilaterally in right superior frontal and an-
terior cingulate cortical regions (Table 1 and Figure 3A).
In the presence of physostigmine, task-specific rCBF in-
creases were observed bilaterally in occipital and right tem-
poral visual extrastriate regions, and in the right anterior
cingulate, with no additional activations in prefrontal re-
gions (Table 1 and Figure 3B). Note the paucity of pre-
frontal activation during physostigmine in Figure 3B. The
Drug  Task interaction (Table 1 and Figure 3C) identified
significantly less rCBF during physostigmine and task in
the right superior frontal, anterior middle frontal, insular,
and inferior frontal cortex, as well as in bilateral occipital
and right temporal visual extrastriate areas. Significantly
greater rCBF during drug relative to placebo was observed
in the left medial visual cortical regions. Increases ob-
served in the right medial visual cortex were seen only
with less strict statistical criteria (voxel level, p < .05; see
Table 1) (Figure 3D). A trend ( p = .07) toward signifi-
cantly greater rCBF during drug relative to placebo was
observed in the right anterior cingulate cortex (Table 1).
The results of the linear trends analysis are displayed
in Figure 4 and are reported in Table 2. During placebo,
rCBF showed a positive linear trend with increased task
delay (i.e., rCBF increased as task delay increased) in
right anterior middle and inferior frontal cortical regions
(Figure 4), and showed a negative linear trend with in-
creased task delay (i.e., rCBF decreased as task delay in-
creased) in occipito-temporal visual extrastriate regions.
During physostigmine infusion, rCBF in occipito-
temporal areas still showed a significant linear trend with
task delay, and the magnitude of the correlation did not
differ from placebo (Figure 4A). In contrast, no significant
linear trend was observed in the prefrontal cortex (Fig-
ure 4B) during physostigmine infusion. The Drug by Task
interaction of the linear model indicates that the dif-
ferences in linear trends observed during placebo and
drug were significant in inferior and middle frontal cor-
tical areas (Figure 4C).
Mean volumes (20 mm) centered around local maxi-
ma that identified peak differences between drug and
placebo conditions in the overall Drug by Task interac-
tion analysis were obtained for selected loci and used for
illustrative purposes to reveal patterns of drug effects
on rCBF. Bar graphs in Figure 5 show mean (±SE) rCBF
during the control task and across task delay conditions
as measured during placebo and physostigmine. Indi-
vidual t tests were used to explain the overall effect in
each region, and asterisks are placed in the figures to
identify differences observed between placebo and drug
conditions, or between task conditions within an infu-
sion condition. In areas of the inferior frontal cortex (Fig-
ure 5A), rCBF increased similarly during each task delay
relative to the sensorimotor control task under placebo,
(i.e., no linear trend between rCBF and task delay; also
see Figure 4) and showed reductions during physo-
stigmine infusion that were selective to the WM delay
conditions (nonsignificant to the 1-sec delay) with no
change in the rCBF response to the control task. In
the superior frontal cortex (Figure 5B), rCBF increases
showed a significant linear trend with task delay during
placebo (the rCBF response in the voxel in Figure 5B
showed a linear trend, but the extent of the correlation
includes only 17 voxels, and therefore, does not appear
in Figure 4). In direct t-test comparisons between the
rCBF response during the control task and each of the
WM delay conditions, only rCBF increases observed
during the long delay conditions (11 and 16 sec) were
Figure 2. Effect of physostigmine on reaction time across task
delays. Mean reaction time (±SE) is shown for the control task and
for each of the WM delay conditions under placebo (dotted lines)
and physostigmine (black lines). Physostigmine significantly reduced
reaction time ( p = .04).
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Table 1. Cortical Regions with Significant rCBF Increases or Decreases during a Parametrically Varied Working Memory Task
before and during Physostigmine Infusion
Placebo Physostigmine Task  Drug Interactiona
Brain Areas BA Hem Z x y zb Z x y z Z x y z
Superior frontal 8/9 R 2.63 19 37 33 5.23 22 32 33
9 R 2.3 24 41 27
9 R 2.78 22 39 30
Anterior middle frontal 9/46 R 3.26 22 43 13
10/46 R 3.46 24 47 16 3.99 20 39 19
45 R 3.01 20 37 9 4.88 22 45 2
10/46 L 2.36 24 41 16
Inferior frontal 8/6 R 2.59 26 3 25 4.07 33 3 25
8/6 R 2.33 26 3 24 3.87 29 5 38
8/6 R 1.97 36 3 32
Inferior frontal/insula 46 R 2.26 38 30 15
45 R 2.58 33 28 5 3.41 31 22 4
45 L 2.28 40 12 14
47/13 L 2.64 36 16 1
45/13 L 2.35 43 16 1
Anterior cingulate 32 R 2.16 15 32 6
24/32 R 2.03 12 30 2
32 R 2.96 10 18 36
32 R 2.86 19 35 2
32 R 2.35 6 28 1 2.78 3 39 5
32 R 3.8 1 41 12c
32 R 3.1 3 49 6c
32 L 1.98 1 34 1 3.1 1 41 2c
Insula 13 R 3.36 31 14 18 3.60 31 18 11
13 R 3.58 38 24 19
Hippocampus R 2.15 27 36 5
Temporal 27 R 2.6 17 36 1 2.06 15 30 5
27 R 2.04 12 29 12
23/31 R 4.48 22 50 25
31 R 3.71 24 60 21
31/19 R 3.59 29 65 21
39/19 R 1.84 26 52 14
39/19 R 2.59 20 42 20
28 L 2.01 22 13 15
Occipital 18 R 5.41 36 71 18 3.21 38 71 18 4.21 34 83 8
18 R 1.84 26 65 18
18 R 2.48 1 71 4
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significant during placebo (Figure 5B). Significantly lower
rCBF was seen during drug relative to the placebo con-
dition for each WM delay conditions, with no change
during the control task. A third pattern was observed
in the anterior middle frontal cortex (Figure 5C), where
rCBF increases during placebo correlated with task delay
(Figure 4), and reductions in rCBF during physostigmine
were restricted to the longer task delays (11 and 16 sec).
As in the superior frontal cortex, rCBF increases during
individual delays were significantly greater than rCBF
response to the control task only during the longer task
delays under placebo conditions (Figure 5C).
Mean rCBF from lateral visual extrastriate regions for
each of the task delay conditions is shown in Figure 5D.
Significant rCBF increases were seen relative to the con-
trol task under placebo conditions, and a negative linear
trend was observed between these increases and the task
delay conditions. Reductions in rCBF were observed un-
der physostigmine infusion selectively during the task
conditions (i.e., not during the control task), but the lin-
ear trend between rCBF and task delay remained un-
changed (Figures 4 and 5D). In contrast, areas of medial
visual regions (Table 1 and Figure 3D) that were not acti-
vated during task under placebo showed significant in-
creases in rCBF under physostigmine infusion, and these
increases were similar across task delays (Figure 5E). Fig-
ure 5F shows physostigmine-induced rCBF increases in
the medial visual cortex and rCBF reductions in the su-
perior frontal imposed on the same axis to highlight the
extent to which changes in the activity in these regions
mirror each other. Again, note the absence of an effect
during the control task for both brain regions.
DISCUSSION
The results of this study support the hypothesis that
augmentation of cholinergic activity reduces task de-
mands, as evidenced by both the reduction in prefrontal
cortical activity in regions that respond differentially to
task demands and to the improvement in task perfor-
mance. The modulation of activity in visual processing
regions, which included both a reduction in activity in
lateral areas (although these regions are still responding
during the task) and an increase in activity in medial
visual areas, may enhance visual processing to result in
an improved visual percept that renders the task easier
and diminishes the need to recruit the prefrontal cortex
to perform the visual WM task.
Under placebo conditions, anterior middle and superior
frontal cortical regions showed linear increases in activity
as WM delay increased, suggesting that these regions re-
spond to changes in WM task demands. Both superior
frontal and anterior middle frontal areas showed dimin-
ished neural activity during cholinergic enhancement and
Table 1. (continued )
Placebo Physostigmine Task  Drug Interactiona
Brain Areas BA Hem Z x y zb Z x y z Z x y z
18 R 2.70 15 71 7c
19 R 3.91 22 71 17 4.26 20 79 1 4.14 34 56 0
19 R 3 17 85 1 4.13 13 67 0 3.90 45 58 21
19 R 1.92 3 60 3
19 R 2.09 17 46 10
18 L 4.01 15 67 7
18 L 3.29 32 71 18 3.65 34 87 5
18 L 3.23 34 83 15 3.37 38 75 18
19 L 3.64 29 89 2 4.45 20 79 10 4.25 31 91 12
Basal ganglia R 3.36 10 21 2 1.83 3 30 2
R 3.28 12 1 7
R 3.17 12 8 3
L 2.45 31 15 8
aSearch volumes for analyses of interaction effects were restricted by the masks that identified brain regions responding to task during placebo and
during drug. Statistical significance was assumed at an individual voxel level of p < .005 and a corrected cluster level of p < .05. Loci shown in BOLD
indicate regions with increases in rCBF during physostigmine. All other loci represent reductions in rCBF during physostigmine.
bTalairach and Tournoux (1988) brain atlas coordinates: x = distance in millimeters to the right (+) or to the left () of the midline; y = distance
anterior (+) or posterior () to the anterior commissure; z = distance superior (+) or inferior () to a horizontal plane through the anterior and
posterior commissures.
cRegion significant at the voxel level of p < .05, uncorrected for the cluster.
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no longer showed modulation in activity in association
with changing task demands, consistent with the hypoth-
esis that cholinergic enhancement reduces task difficulty.
The improvement in task performance also is con-
sistent with the interpretation that the WM task became
easier to perform during cholinergic enhancement,
and provides strong support to our interpretation that
changes in neural activity reflect enhanced neural pro-
cessing. Despite the fact that we have performance data
on only half of the subjects, this effect of physostigmine
on reaction time is consistent with effects that we re-
ported previously using physostigmine and this face
WM task without variation in the delay conditions (Freo
et al., 2005; Furey, Pietrini, Alexander, Schapiro, et al.,
2000; Furey, Pietrini, & Haxby, 2000; Furey et al., 1997);
others have reported using other tasks (Bentley, Husain,
& Dolan, 2004; Bentley, Vuilleumier, Thiel, Driver, &
Dolan, 2003b). Thus, the behavioral finding primarily rep-
resents a replication of previously reported effects of cho-
linergic enhancement. In the current dataset, we also see
evidence of a reduction in reaction time during the sen-
sorimotor control condition. Previously, we found that
cholinergic enhancement selectively modulated perfor-
mance during task conditions with no effect on the con-
trol condition with sample sizes larger than we have in the
current reaction time analysis (Furey, Pietrini, Haxby, &
Drevets, 2007; Furey, Pietrini, & Haxby, 2000). The effect
on the control condition observed in the current study
should be considered within the larger literature.
Different prefrontal brain regions showed different pat-
terns of response to cholinergic potentiation. The ante-
rior middle frontal cortex showed systematic increases in
neural response as task difficulty increased under placebo
conditions, and in direct comparisons, only longer delays
were associated with significant increases in activity over
the control task. This region, which responded systemat-
ically to task demand in the absence of drug, consistently
has been associated with WM maintenance processes
(D’Esposito, Postle, & Rypma, 2000; D’Esposito, Postle,
Ballard, & Lease, 1999). Physostigmine infusion had no
effect on response in this region to the control task or to
shorter task delays, but did reduce neural response se-
lectively to the longer delay conditions when the main-
tenance conditions were more demanding.
Figure 3. Effect of
physostigmine on brain activity
during WM. Brain regions
showing significant increases in
rCBF during a parametrically
varied visual WM task as
compared to a sensorimotor
control condition during
placebo (A) and physostigmine
(B) infusions are projected
onto the right hemisphere of a brain template and displayed in the top row. The extent to which these effects are expressed in each of the
delay conditions is displayed in each of the columns below. The Task by Drug interactions are displayed with significant rCBF decreases
(C) and increases (D) shown separately. For the placebo and physostigmine conditions, the overlays are thresholded as described for the
comparable overall analysis. The overlays for the interaction conditions are the result of a subtraction.
Figure 4. Brain areas showing
correlations between rCBF
response and task difficulty.
Regions showing significant
positive (yellow) and negative
(green) correlations between
rCBF and task delay conditions
have been superimposed on
the right hemisphere of a brain
template for placebo (top),
physostigmine (middle), and
the Task  Drug interaction
(bottom). Example
scatterplots with fitted
regression lines as observed
during placebo (red) and
physostigmine (blue) are
shown for a representative
lateral visual cortical region
(left plot) and an anterior
middle frontal cortical locus
(right plot).
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The superior frontal cortex also showed increased neu-
ral activity as task demands increased during placebo, and
again only longer delays were associated with significant
increases in activity in direct comparisons. However, in
this region, we observed significant reductions in neural
activity at each of the task delays during physostigmine
administration, including the shorter delay conditions.
Previous WM functional studies demonstrated that more
dorsally located prefrontal regions subserve the manipu-
lation and retrieval components of WM more than the
maintenance of information (D’Esposito et al., 1999,
2000). As our WM paradigm has no manipulation require-
ment, this region likely is contributing to the retrieval
aspects of our task. The reduction in neural activity ob-
served during each of the delay conditions suggests that
the retrieval of information may also be less demanding
following cholinergic enhancement, reducing the need to
recruit this prefrontal area. Moreover, requirements for
the retrieval of information are similar across delay con-
ditions, and therefore, we would expect that the influ-
ence of cholinergic enhancement also would be similar
over delays, consistent with our observations in this area.
The inferior frontal region showed a third pattern of
response to drug where increased neural activity was ob-
served to each of the task delay conditions during pla-
cebo, but the magnitude of response did not vary with
delay, suggesting that this region responds to WM re-
quirements during the variable delays, but it is not af-
fected directly by task demands. During cholinergic
enhancement, activity in this region decreased similarly
across delay conditions. Thus, prefrontal brain regions
recruited during WM that are delay independent but,
nonetheless, important to WM function, also are modu-
lated by cholinergic enhancement.
Areas of the medial visual cortex selectively increased
neural activity during physostigmine infusion in re-
sponse to the WM task, with no change in response to
the control task, whereas the more lateral regions of vi-
sual processing areas had reduced activity. As choliner-
gic function is associated with signal-to-noise processing
(Everitt & Robbins, 1997; Murphy & Sillito, 1991; Sato,
Hata, Masui, & Tsumoto, 1987; Sillito & Kemp, 1983), both
the increased activity observed in medial visual areas,
together with the decreased activity in lateral visual pro-
cessing areas, would be consistent with a cholinergically
mediated enhancement of perceptual processing. Lateral
ventral extrastriate regions showed negative correlations
between WM task delay and neural activity under placebo,
Table 2. Cortical Regions Showing Positive or Negative Correlations between rCBF Response and Task Difficulty before and
during Physostigmine Infusion
Placeboa Physostigmine Task  Drug Interaction
Brain Areas BA Hem Z Score x y zb Z Score x y z Z Score x y z
Positive Correlation
Anterior middle frontal 9/46 R 2.97 26 45 13 3.45 26 45 13
Inferior frontal 45 R 2.89 33 28 5
Cingulate 32 R 2.83 19 37 2 2.17 20 32 2
34 R 2.1 19 4 11
Basal ganglia R 2.59 8 1 3 2.9 13 3 3
R 2.13 6 10 4 1.91 17 4 4
R 2.05 8 16 3
Negative Correlation
Occipital 18 R 4.65 31 79 11 4.59 31 69 21
R 4.01 41 63 18 3.77 31 83 15
R 2.93 13 87 22 3.74 26 85 22
18 L 2.87 34 85 19 2.93 27 71 18
18 L 2.58 25 67 14 2.8 40 71 18
19 L 2.18 29 91 16 2.63 25 85 2
aSearch volumes for correlation analyses were restricted by the masks that identified brain regions responding to task during placebo and during
drug. Statistical significance was assumed at an individual voxel level of p < .005 and required 50 contiguous significant voxels.
bTalairach and Tournoux (1988) brain atlas coordinates: x = distance in millimeters to the right (+) or to the left () of the midline; y = distance
anterior (+) or posterior () to the anterior commissure; z = distance superior (+) or inferior () to a horizontal plane through the anterior and
posterior commissures.
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consistent with the inherent reduction in stimulus input
over time as WM delay increases. Although the overall
magnitude of response decreased in lateral visual cortical
areas during physostigmine, this region continued to re-
spond during the task and the negative correlation was
uninfluenced by drug. This reduction in activity is consis-
tent with our previous findings (Freo et al., 2005; Furey,
Pietrini, & Haxby, 2000; Furey et al., 1997), and likely re-
flects signal-to-noise modulation (Furey, Pietrini, & Haxby,
2000) (see below). In contrast, medial visual cortical re-
gions that were not recruited differentially relative to the
control task during placebo showed significant increases
in neural activity during enhancement of cholinergic activ-
ity selectively during WM task conditions. This is one of
two cortical regions that showed increased activity in re-
sponse to cholinergic enhancement. This finding is con-
sistent with our previous results demonstrating a negative
correlation between physostigmine-induced decreases in
task reaction time and increases in rCBF in early visual
processing regions (Furey, Pietrini, Alexander, Schapiro,
et al., 2000). Others also have observed task-specific in-
creases in activity in visual extrastriate areas following cho-
linergic enhancement (Kumari, Aasen, Ffytche, Williams, &
Sharma, 2006; Rombouts, Barkhof, Van Meel, & Scheltens,
2002). Bentley et al. (2004) showed that during a spatial
WM task, physostigmine reduces activity in the inferior
prefrontal cortex, as well as reduced activity in the primary
visual cortex and increased activity in extrastriate visual
regions. Other studies similarly have observed both in-
creases and decreases in neural activity in different visual
processing areas during cholinergic enhancement and cog-
nitive tasks (Freo et al., 2005; Bentley et al., 2003a; Furey,
Pietrini, Alexander, Schapiro, et al., 2000). Such findings
similarly have been discussed in terms of signal-to-noise
processing effects of acetylcholine (Bentley et al., 2004;
Furey, Pietrini, & Haxby, 2000).
The selectivity of the effects reported by our study
should be highlighted. Previously, we demonstrated that
physostigmine-induced reductions in right prefrontal cor-
tical activity were highly selective to the task condition,
when compared to a resting state rather than a task-
specific control condition (Furey et al., 1997). The earlier
result was critical to demonstrate that physostigmine did
not alter blood flow at rest while modulating neural
activity during the task. Here we have demonstrated that
the cholinergically mediated rCBF changes in prefrontal
cortical regions and in visual extrastriate processing areas
are selective to task conditions, with no effect on neural
activity during a sensorimotor control task that had no
WM component.
The mechanism by which acetylcholine modulates neu-
ral activity is as yet unclear. The increased activity in
the visual cortex may occur via top–down attentional in-
fluences of prefrontal regions that continue to respond
Figure 5. Effect of physostigmine on volume mean rCBF across task delays. Volumes of 20 mm were averaged around loci identified in the
Task  Drug interaction, and mean rCBF (±SE) values are plotted for the control task and each WM delay as obtained during placebo (red)
and physostigmine (blue). Representative volumes are shown from the inferior frontal cortex (A), the superior frontal cortex (B), the anterior
middle frontal cortex (C), the lateral visual extrastriate cortex (D), and the medial visual cortex (F). Results of t tests performed to characterize
significant Task  Drug interactions are indicated with asterisks overlying lines that indicate the comparisons; asterisks with solid lines are
significant at p < .05 and asterisks with dashed lines represent trends at p < .10.
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under conditions of increased cholinergic function during
the WM task, such as the anterior cingulate cortex. Alter-
natively, increased activity in the visual cortex may occur
through direct effects of cholinergic activity on cortical
stimulus processing. Evidence suggests that acetylcholine
may modulate neural responses through signal-to-noise
mechanisms (Hasselmo, 1995; Murphy & Sillito, 1991;
Sato et al., 1987). Investigators have demonstrated that
the direct application of acetylcholine to the visual cortex
enhances and sharpens the selectivity of neural responses
to specific stimulus features, including stimulus direction
and orientation (i.e., increased responses to the preferred
features and reduced responses to the less preferred fea-
tures). These findings indicate that, in the absence of
cholinergic modulation of the prefrontal cortex, increas-
ing cholinergic activity enhances neural responses during
the processing of visual stimuli. In the current context,
increased cholinergic activity may improve the percep-
tual representation of the encoded stimulus by boosting
signal-to-noise, either by increasing responses to signal or
by reducing responses to noise. The enhanced perceptual
representation then renders the task easier, across delay
conditions, and reduces the need for prefrontal contri-
butions when performing WM.
An alternative explanation of our findings might be
that physostigmine has direct effects on the prefrontal
cortex to inhibit activity, and the medial visual cortex is
recruited further to compensate for this effect. One ar-
gument against this alternative comes from our previous
work (Furey et al., 1997) demonstrating that, during a
rest condition, no change in neural activity is observed
in the prefrontal cortex during increased cholinergic
function with physostigmine, but rather task-specific de-
creases exclusively were observed.
An attractive alternative explanation for the reductions
in neural activity seen in prefrontal WM regions, as well
as in lateral visual processing areas, is the possibility that
increased cholinergic function may enhance neural ef-
ficiency. A growing literature has demonstrated that
increased neural efficiency is associated with reduced
overall neural activity, resulting in increased focality of
neural response (Rypma et al., 2006; Sayala, Sala, &
Courtney, 2006; Rypma, Berger, Genova, Rebbechi, &
D’Esposito, 2005). This alternative would argue that the
entire WM network requires less activity due to overall
improved efficiency. Although this interpretation cannot
be ruled out, the increase in neural activity observed in
medial visual cortical areas during cholinergic enhance-
ment, that were not recruited prior to drug, would be
difficult to explain. Alternatively, we are arguing that the
WM system is working more efficiently, requiring less in-
put from prefrontal brain regions and lateral visual re-
gions as a result of an enhanced representation of the
visual information in the medial visual cortex.
Prefrontal brain regions that showed increased neural
response as a function of WM load had reduced activity
following the administration of scopolamine, a cholinergic
antagonist (Bullmore et al., 2003), although one might
expect, based on our findings, that the prefrontal cortex
would increase responses to task during scopolamine.
This also may be explained via signal-to-noise mecha-
nisms, whereby regions responsive to load showed dimin-
ished selectivity in response, resulting in increased noise,
producing an overall reduction in measured signal. In this
case, however, we would expect to see some impairment
in behavioral performance consistent with impaired pro-
cessing, but no effect on behavior was observed (Bullmore
et al., 2003). This discrepancy also may be due simply to
the different tasks used in each of these studies.
Researchers have shown that prefrontal regions that
are implicated in cognitive task performance also are in-
volved in motor response preparation, at least for some
tasks (Schumacher, Cole, & D’Esposito, 2007). As a re-
sult, we should note that the cholinergically mediated
reduction in reaction time may affect activity in prefron-
tal regions as a result of associated changes in motor re-
sponse preparation.
One might question the experimental design where
the drug infusion always followed the placebo infusion.
Previously, we showed that task-associated rCBF response
magnitude did not vary over repetitions of a WM task in
prefrontal brain regions, either during physostigmine or
during placebo (Furey, Pietrini, Alexander, Mentis, et al.,
2000). Although the benefits of randomization will not be
argued, we designed the study with the knowledge that
task repetition per se would not alter the rCBF measure-
ment. The alternative in a within-subjects design would
be to randomize the infusion conditions over two sepa-
rate occasions, but the invasiveness of the arterial line
renders this option unfavorable.
In conclusion, the results reported here extend our pre-
vious findings by demonstrating that augmentation of cho-
linergic system activity during a visual WM for faces task
reduces WM demands, and thus the task becomes easier,
diminishing the need for prefrontal involvement. As in pre-
vious studies, we observed modulation in visual process-
ing areas during physostigmine infusion that is consistent
with enhanced processing of visual input. The absence of
modulation in neural response in prefrontal WM regions
as task demands change is consistent with the hypothesis
that improved perceptual representations of stimuli re-
duces task difficulty and the need to recruit prefrontal areas.
Acknowledgments
This work was supported by the National Institute on Aging in-
tramural program, and in part by grants from the I.R.I.S. Foun-
dation (Livorno, Italy).
We thank Peter Herscovitch and the technologists of the NIH
positron emission tomography program, and Joanna Szczepanik
and Richard Desmond for technical support.
Reprint requests should be sent to Maura L. Furey, Mood and
Anxiety Disorders Program, NIMH/NIH, Room 115B, 15K North
Drive, Bethesda, MD 20892, or via e-mail: mfurey@mail.nih.gov.
Furey et al. 1351
REFERENCES
Baddeley, A. (2003). Working memory and language: An
overview. Journal of Communication Disorders, 36,
189–208.
Baddeley, A., Logie, R., Bressi, S., Della Sala, S., & Spinnler, H.
(1986). Dementia and working memory. Quarterly
Journal of Experimental Psychology A, 38, 603–618.
Barch, D. M., Braver, T. S., Nystrom, L. E., Forman, S. D.,
Noll, D. C., & Cohen, J. D. (1997). Dissociating working
memory from task difficulty in human prefrontal cortex.
Neuropsychologia, 35, 1373–1380.
Bentley, P., Husain, M., & Dolan, R. J. (2004). Effects of
cholinergic enhancement on visual stimulation, spatial
attention, and spatial working memory. Neuron, 41,
969–982.
Bentley, P., Vuilleumier, P., Thiel, C. M., Driver, J., & Dolan,
R. J. (2003a). Cholinergic enhancement modulates neural
correlates of selective attention and emotional processing.
Neuroimage, 20, 58–70.
Bentley, P., Vuilleumier, P., Thiel, C. M., Driver, J., & Dolan,
R. J. (2003b). Effects of attention and emotion on repetition
priming and their modulation by cholinergic enhancement.
Journal of Neurophysiology, 90, 1171–1181.
Braver, T. S., Cohen, J. D., Nystrom, L. E., Jonides, J., Smith,
E. E., & Noll, D. C. (1997). A parametric study of prefrontal
cortex involvement in human working memory.
Neuroimage, 5, 49–62.
Bullmore, E., Suckling, J., Zelaya, F., Long, C., Honey, G.,
Reed, L., et al. (2003). Practice and difficulty evoke
anatomically and pharmacologically dissociable brain
activation dynamics. Cerebral Cortex, 13, 144–154.
D’Esposito, M., Postle, B. R., Ballard, D., & Lease, J. (1999).
Maintenance versus manipulation of information held
in working memory: An event-related fMRI study. Brain
and Cognition, 41, 66–86.
D’Esposito, M., Postle, B. R., & Rypma, B. (2000). Prefrontal
cortical contributions to working memory: Evidence from
event-related fMRI studies. Experimental Brain Research,
133, 3–11.
Dawson, G. R., & Iversen, S. D. (1993). The effects of novel
cholinesterase inhibitors and selective muscarinic receptor
agonists in tests of reference and working memory.
Behavioural Brain Research, 57, 143–153.
Everitt, B. J., & Robbins, T. W. (1997). Central cholinergic
systems and cognition. Annual Review of Psychology,
48, 649–684.
Freo, U., Ricciardi, E., Pietrini, P., Schapiro, M. B., Rapoport,
S. I., & Furey, M. L. (2005). Pharmacological modulation
of prefrontal cortical activity during a working memory
task in young and older humans: A PET study with
physostigmine. American Journal of Psychiatry, 162,
2061–2070.
Friston, K. J., Holmes, A. P., Worsley, K. J., Poline, J.-B., Frith,
C. D., & Frackowiak, R. S. J. (1995). Statistical parametric
maps in functional imaging: A general linear approach.
Human Brain Mapping, 2, 189–210.
Furey, M. L., Pietrini, P., Alexander, G. E., Mentis, M. J.,
Szczepanik, J., Shetty, U., et al. (2000). Time course
of pharmacodynamic and pharmacokinetic effects of
physostigmine assessed by functional brain imaging in
humans. Pharmacology, Biochemistry and Behavior,
66, 475–481.
Furey, M. L., Pietrini, P., Alexander, G. E., Schapiro, M. B.,
& Horwitz, B. (2000). Cholinergic enhancement improves
performance on working memory by modulating the
functional activity in distinct brain regions: A positron
emission tomography regional cerebral blood flow
study in healthy humans. Brain Research Bulletin, 51,
213–218.
Furey, M. L., Pietrini, P., & Haxby, J. V. (2000). Cholinergic
enhancement and increased selectivity of perceptual
processing during working memory. Science, 290,
2315–2319.
Furey, M. L., Pietrini, P., Haxby, J. V., Alexander, G. E.,
Lee, H. C., VanMeter, J., et al. (1997). Cholinergic
stimulation alters performance and task-specific
regional cerebral blood flow during working memory.
Proceedings of the National Academy of Sciences, U.S.A.,
94, 6512–6516.
Furey, M. L., Pietrini, P., Haxby, J. V., & Drevets, W. C.
(2007). Selective effects of cholinergic modulation
on task performance during selective attention.
Neuropsychopharmacology, 33, 913–923.
Glasky, A. J., Melchior, C. L., Pirzadeh, B., Heydari, N.,
& Ritzmann, R. F. (1994). Effect of AIT-082, a purine
analog, on working memory in normal and aged mice.
Pharmacology, Biochemistry and Behavior, 47, 325–329.
Grady, C. L., Horwitz, B., Pietrini, P., Mentis, M. J., Ungerleider,
L. G., Rapoport, S. I., et al. (1996). Effect of task difficulty
on cerebral blood flow during perceptual matching of
faces. Human Brain Mapping, 4, 227–239.
Grady, C. L., McIntosh, A. R., Bookstein, F., Horwitz, B.,
Rapoport, S. I., & Haxby, J. V. (1998). Age-related changes
in regional cerebral blood flow during working memory
for faces. Neuroimage, 8, 409–425.
Hasselmo, M. E. (1995). Neuromodulation and cortical
function: Modeling the physiological basis of behavior.
Behavioural Brain Research, 67, 1–27.
Haxby, J. V., Ungerleider, L. G., Horwitz, B., Rapoport, S. I.,
& Grady, C. L. (1995). Hemispheric differences in neural
systems for face working memory: A PET–rCBF study.
Human Brain Mapping, 3, 68–82.
Kumari, V., Aasen, I., Ffytche, D., Williams, S. C., &
Sharma, T. (2006). Neural correlates of adjunctive
rivastigmine treatment to antipsychotics in schizophrenia:
A randomized, placebo-controlled, double-blind fMRI
study. Neuroimage, 29, 545–556.
Mesulam, M. M. (1995). Cholinergic pathways and the
ascending reticular activating system of the human
brain. Annals of the New York Academy of Sciences,
757, 169–179.
Murphy, P. C., & Sillito, A. M. (1991). Cholinergic enhancement
of direction selectivity in the visual cortex of the cat.
Neuroscience, 40, 13–20.
Oduro, K. A. (1975). Glycopyrrolate methobromide:
2. Comparison with atropine sulphate in anaesthesia.
Canadian Anaesthetists’ Society Journal, 22, 466–473.
Robbins, T. W. (1997). Arousal systems and attentional
processes. Biological Psychology, 45, 57–71.
Rombouts, S. A., Barkhof, F., Van Meel, C. S., & Scheltens, P.
(2002). Alterations in brain activation during cholinergic
enhancement with rivastigmine in Alzheimer’s disease.
Journal of Neurology, Neurosurgery and Psychiatry,
73, 665–671.
Rusted, J. M., & Warburton, D. M. (1988). The effects of
scopolamine on working memory in healthy young
volunteers. Psychopharmacology (Berlin), 96, 145–152.
Rypma, B., Berger, J. S., Genova, H. M., Rebbechi, D.,
& D’Esposito, M. (2005). Dissociating age-related
changes in cognitive strategy and neural efficiency
using event-related fMRI. Cortex, 41, 582–594.
Rypma, B., Berger, J. S., Prabhakaran, V., Bly, B. M.,
Kimberg, D. Y., Biswal, B. B., et al. (2006). Neural
correlates of cognitive efficiency. Neuroimage, 33,
969–979.
1352 Journal of Cognitive Neuroscience Volume 20, Number 7
Sarter, M., & Bruno, J. P. (2000). Cortical cholinergic
inputs mediating arousal, attentional processing and
dreaming: Differential afferent regulation of the basal
forebrain by telencephalic and brainstem afferents.
Neuroscience, 95, 933–952.
Sarter, M., Nelson, C. L., & Bruno, J. P. (2005). Cortical
cholinergic transmission and cortical information
processing in schizophrenia. Schizophrenia Bulletin,
31, 117–138.
Sato, H., Hata, Y., Masui, H., & Tsumoto, T. (1987). A
functional role of cholinergic innervation to neurons
in the cat visual cortex. Journal of Neurophysiology,
58, 765–780.
Sayala, S., Sala, J. B., & Courtney, S. M. (2006). Increased
neural efficiency with repeated performance of a
working memory task is information-type dependent.
Cerebral Cortex, 16, 609–617.
Schumacher, E. H., Cole, M. W., & D’Esposito, M.
(2007). Selection and maintenance of stimulus–
response rules during preparation and performance
of a spatial choice-reaction task. Brain Research, 1136, 77–87.
Sillito, A. M., & Kemp, J. A. (1983). Cholinergic modulation
of the functional organization of the cat visual cortex.
Brain Research, 289, 143–155.
Talairach, J., & Tournoux, P. (1988). Co-planar stereotaxic
atlas of the human brain. New York: Thieme.
Terry, A. V., Jr., Jackson, W. J., & Buccafusco, J. J. (1993).
Effects of concomitant cholinergic and adrenergic
stimulation on learning and memory performance by
young and aged monkeys. Cerebral Cortex, 3, 304–312.
Furey et al. 1353
